AptarGroup Inc (ATR)vsResMed Inc (RMD)
ATR
AptarGroup Inc
$125.45
+1.66%
HEALTHCARE · Cap: $7.85B
RMD
ResMed Inc
$221.97
-0.73%
HEALTHCARE · Cap: $32.46B
Smart Verdict
WallStSmart Research — data-driven comparison
ResMed Inc generates 44% more annual revenue ($5.65B vs $3.93B). RMD leads profitability with a 27.0% profit margin vs 9.2%. RMD appears more attractively valued with a PEG of 1.31. RMD earns a higher WallStSmart Score of 67/100 (B-).
ATR
Hold49
out of 100
Grade: D+
RMD
Strong Buy67
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-40.7%
Fair Value
$99.48
Current Price
$125.45
$25.97 premium
Margin of Safety
-24.1%
Fair Value
$209.18
Current Price
$221.97
$12.79 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Strong operational efficiency at 30.9%
Safe zone — low bankruptcy risk
Every $100 of equity generates 23 in profit
Keeps 27 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Generating 1.6B in free cash flow
Areas to Watch
Weak financial health signals
Expensive relative to growth rate
Earnings declined 18.6%
2.4% earnings growth
Comparative Analysis Report
WallStSmart ResearchBull Case : ATR
ATR has a balanced fundamental profile.
Bull Case : RMD
The strongest argument for RMD centers on Operating Margin, Altman Z-Score, Return on Equity. Profitability is solid with margins at 27.0% and operating margin at 30.9%. PEG of 1.31 suggests the stock is reasonably priced for its growth.
Bear Case : ATR
The primary concerns for ATR are Piotroski F-Score, PEG Ratio, EPS Growth.
Bear Case : RMD
The primary concerns for RMD are EPS Growth.
Key Dynamics to Monitor
ATR profiles as a value stock while RMD is a mature play — different risk/reward profiles.
RMD carries more volatility with a beta of 0.77 — expect wider price swings.
RMD is growing revenue faster at 8.6% — sustainability is the question.
RMD generates stronger free cash flow (1.6B), providing more financial flexibility.
Bottom Line
RMD scores higher overall (67/100 vs 49/100), backed by strong 27.0% margins. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
AptarGroup Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
AptarGroup, Inc. offers a range of packaging, dispensing and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectables, and food and beverage markets. The company is headquartered in Crystal Lake, Illinois.
Visit Website →ResMed Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?